×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Heart Pump Devices Market

ID: MRFR/HC/52757-HCR
200 Pages
Garvit Vyas
October 2025

India Heart Pump Devices Market Research Report: By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination Therapy (DT), Others) andBy End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutes, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Heart Pump Devices Market Infographic
Purchase Options

India Heart Pump Devices Market Summary

As per Market Research Future analysis, the India Heart Pump Devices Market size was estimated at 46.32 USD Million in 2024. The Heart Pump-devices market is projected to grow from 56.31 USD Million in 2025 to 396.68 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 21.5% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The India heart pump-devices market is poised for substantial growth driven by technological advancements and increasing healthcare needs.

  • Technological advancements in heart pump devices are enhancing treatment outcomes and patient experiences.
  • The increasing prevalence of cardiovascular diseases is driving demand for innovative heart pump solutions.
  • Government initiatives and support are fostering a conducive environment for market expansion.
  • The rising geriatric population and increased healthcare expenditure are key drivers propelling the heart pump-devices market forward.

Market Size & Forecast

2024 Market Size 46.32 (USD Million)
2035 Market Size 396.68 (USD Million)
CAGR (2025 - 2035) 21.56%

Major Players

Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), Cleveland Heart (US), CardiacAssist (US), Syncardia (US), Getinge (SE), LivaNova (GB)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

India Heart Pump Devices Market Trends

The heart pump-devices market is currently experiencing notable growth, driven by advancements in technology and increasing prevalence of cardiovascular diseases. The rise in awareness regarding heart health, coupled with a growing aging population, appears to be propelling demand for innovative devices. Furthermore, government initiatives aimed at improving healthcare infrastructure and access to medical devices are likely to enhance market dynamics. As healthcare professionals increasingly adopt these devices, the market is poised for further expansion, reflecting a shift towards more effective treatment options for patients with heart conditions. In addition, the India Heart Pump Devices Market is witnessing a surge in research and development activities. Manufacturers are focusing on creating devices that are not only more efficient but also user-friendly. This trend suggests a potential for improved patient outcomes and satisfaction. Moreover, collaborations between healthcare providers and technology firms may lead to the introduction of cutting-edge solutions, thereby transforming the landscape of cardiac care. Overall, the market is on a trajectory of growth, driven by innovation and a commitment to enhancing patient care.

Technological Advancements

Recent innovations in heart pump-devices are enhancing their efficiency and effectiveness. Manufacturers are integrating advanced materials and smart technologies, which may lead to improved patient outcomes. These developments suggest a shift towards more personalized treatment options.

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular conditions is driving demand for heart pump-devices. As more individuals seek treatment, healthcare providers are likely to adopt these devices, indicating a growing market presence.

Government Initiatives and Support

Government efforts to improve healthcare access and infrastructure are positively impacting the heart pump-devices market. Initiatives aimed at promoting medical technology adoption may facilitate market growth and enhance patient care.

India Heart Pump Devices Market Drivers

Rising Geriatric Population

The heart pump-devices market in India is experiencing growth due to the increasing geriatric population. As individuals age, the prevalence of cardiovascular diseases tends to rise, necessitating advanced medical interventions. By 2025, it is projected that approximately 10% of India's population will be over 60 years old, leading to a higher demand for heart pump devices. This demographic shift is prompting healthcare providers to invest in innovative heart pump technologies to cater to the needs of older patients. Furthermore, the aging population is likely to drive the need for more specialized healthcare services, thereby expanding the heart pump-devices market. The focus on improving the quality of life for elderly patients with heart conditions is expected to further stimulate market growth, as families seek effective solutions for managing chronic health issues.

Increased Healthcare Expenditure

India's rising healthcare expenditure is a crucial driver for the heart pump-devices market. With the government and private sectors investing more in healthcare infrastructure, the availability of advanced medical technologies is improving. In recent years, healthcare spending has increased to around 3.5% of GDP, indicating a growing commitment to enhancing healthcare services. This trend is likely to facilitate the adoption of heart pump devices, as hospitals and clinics seek to provide cutting-edge treatments for cardiovascular diseases. Additionally, increased funding for research and development in medical technology may lead to the introduction of innovative heart pump solutions, further expanding the market. As healthcare facilities upgrade their equipment, the demand for heart pump devices is expected to rise, reflecting a broader trend towards modernization in the healthcare sector.

Growing Awareness of Heart Health

The heart pump-devices market is benefiting from a growing awareness of heart health among the Indian population. Public health campaigns and educational initiatives are increasingly emphasizing the importance of cardiovascular health, leading to more individuals seeking medical advice and treatment. This heightened awareness is likely to result in earlier diagnosis and intervention for heart-related issues, thereby increasing the demand for heart pump devices. Moreover, as patients become more informed about available treatment options, they may actively seek out advanced technologies, contributing to market growth. The emphasis on preventive healthcare is also encouraging individuals to adopt healthier lifestyles, which may reduce the overall burden of cardiovascular diseases in the long term. Consequently, the heart pump-devices market is poised to expand as awareness continues to rise.

Supportive Regulatory Environment

A supportive regulatory environment is fostering growth in the heart pump-devices market. The Indian government has been streamlining the approval processes for medical devices, making it easier for manufacturers to bring new products to market. This regulatory support is crucial for encouraging innovation and investment in the heart pump sector. Additionally, initiatives aimed at improving healthcare access and affordability are likely to enhance the market landscape. As regulations become more favorable, companies may be more inclined to invest in research and development, leading to the introduction of advanced heart pump technologies. The overall effect of a supportive regulatory framework is expected to create a conducive environment for market expansion, ultimately benefiting patients in need of heart pump devices.

Technological Innovations in Medical Devices

Technological innovations are playing a pivotal role in shaping the heart pump-devices market. The introduction of minimally invasive procedures and advanced materials is enhancing the efficacy and safety of heart pump devices. Innovations such as wearable heart monitors and remote patient management systems are also gaining traction, allowing for better patient outcomes. As these technologies evolve, they are likely to attract more healthcare providers to adopt heart pump devices, thereby expanding the market. Furthermore, the integration of artificial intelligence and machine learning in device design and patient monitoring could lead to more personalized treatment options. This trend towards innovation is expected to drive competition among manufacturers, resulting in a wider range of products available in the heart pump-devices market.

Market Segment Insights

By Product: Left Ventricular Assist Devices (Largest) vs. Right Ventricular Assist Devices (Fastest-Growing)

In the India heart pump-devices market, the distribution of market share among various product segments reveals that Left Ventricular Assist Devices dominate the landscape, owing to their extensive use in advanced heart failure treatment. Other products such as Right Ventricular Assist Devices and Intra-Aortic Balloon Pumps follow, with a smaller but important share in the market. The growing adoption of bi-ventricular assist designs and percutaneous systems is indicative of the shifting preferences towards more integrated solutions. Growth trends in this segment are driven by the rising prevalence of heart diseases and technological advancements in pump design. The demand for minimally invasive procedures is increasing, especially for devices like Percutaneous Ventricular Assist Devices. Additionally, factors such as improved healthcare infrastructure and rising awareness significantly contribute to the growth of the heart pump-devices market as it moves towards integrating innovative treatments.

Ventricular Assist Devices (Dominant) vs. Intra-Aortic Balloon Pumps (Emerging)

Ventricular Assist Devices, particularly Left Ventricular Assist Devices, are at the forefront of the India heart pump-devices market, recognized for their crucial role in managing severe heart conditions. These devices offer patients extended survival rates and improved quality of life. Conversely, Intra-Aortic Balloon Pumps represent an emerging category with increasing usage due to their efficacy in acute cases and their non-invasive nature. The development of smaller, lightweight designs has boosted their acceptance among healthcare professionals. Both segments attract significant interest, yet Ventricular Assist Devices continue to lead, while Intra-Aortic Balloon Pumps are rapidly gaining traction, particularly within critical care settings.

By Device Type: Implantable heart pump devices (Largest) vs. Extracorporeal heart pump devices (Fastest-Growing)

In the India heart pump-devices market, implantable heart pump devices hold a significant market share, owing largely to their established presence and effectiveness in treating severe heart conditions. These devices are widely adopted due to their long-term benefits and positive clinical outcomes. On the other hand, extracorporeal heart pump devices are witnessing rapid growth, particularly in emergency care and surgical procedures, as healthcare professionals increasingly recognize their importance in supporting patients during critical phases. The growth trend for implantable heart pump devices is driven by rising incidences of heart-related diseases and advancements in technology, leading to enhanced patient outcomes and experiences. Conversely, the extracorporeal heart pump device segment is growing swiftly due to an increase in awareness among clinicians and patients about the benefits of these devices. The surge in surgical procedures and the focus on improving healthcare infrastructure further propel the demand for both types of devices, reflecting their significance in the evolving landscape of cardiac care.

Implantable heart pump devices (Dominant) vs. Extracorporeal heart pump devices (Emerging)

Implantable heart pump devices are categorized by their longevity and efficacy in treating chronic heart conditions, making them a dominant choice in therapeutic interventions. Their design encourages patient compliance and improves quality of life, which solidifies their market position. Meanwhile, extracorporeal heart pump devices serve as a crucial, emerging option that provides temporary circulatory support during surgical procedures or acute care situations. Their rapid adoption in critical care units and the growing emphasis on minimally invasive procedures elevate their profile. Both segment types exhibit unique advantages that cater to specific patient needs, thereby shaping the future trajectory of the India heart pump-devices market.

By Therapy: Bridge-to-transplant (Largest) vs. Destination therapy (Fastest-Growing)

In the India heart pump-devices market, the Bridge-to-transplant (BTC) segment holds the largest share due to its wide acceptance among healthcare practitioners and patients. This segment is noted for its effectiveness in extending lives by providing temporary support to patients awaiting heart transplants. Conversely, the Destination therapy (DT) segment, while smaller in size, is rapidly growing as more patients seek permanent solutions to heart failure, showcasing an evolving preference towards advanced therapeutic options. The growth trends in these segments are influenced by various factors, including increasing prevalence of heart diseases and advancements in medical technology. The rising awareness among patients and healthcare professionals about the benefits of heart pump devices further drives the adoption of both BTC and DT solutions. Moreover, government initiatives to improve healthcare infrastructure are expected to enhance access to these life-saving devices across the country.

Bridge-to-transplant (Dominant) vs. Destination therapy (Emerging)

The Bridge-to-transplant (BTC) segment is characterized by its significant market dominance, largely due to its established role in cardiac care for patients awaiting transplants. It represents a critical option for managing severe heart failure, providing essential support before patients undergo transplantation. On the other hand, the Destination therapy (DT) segment is emerging as a vital alternative for patients who are not candidates for transplant, offering long-term therapy and improved quality of life. This segment is witnessing increased investment and research, contributing to innovative device development that caters specifically to the unique needs of heart failure patients, thus reinforcing its position in the India heart pump-devices market.

By End-User: Hospitals & Clinics (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The market share distribution among the end-user segments in the India heart pump-devices market reveals that Hospitals & Clinics hold the largest share. These facilities are equipped with sophisticated technologies and have a constant influx of patients requiring heart pump devices for various cardiovascular conditions. In contrast, Ambulatory Surgical Centers are emerging as a significant force, meeting the growing demand for minimally invasive procedures and patient convenience, thereby attracting a larger patient base. Growth trends within this segment are primarily driven by the increasing prevalence of heart diseases, ongoing advancements in medical technology, and a surge in healthcare infrastructure investments. Hospitals & Clinics are likely to continue leveraging their established reputations to capture market share, while Ambulatory Surgical Centers focus on expedited treatment processes, cost-efficiency, and patient-centered care, positioning themselves as the fastest-growing segment within this market.

Hospitals & Clinics (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals & Clinics serve as the dominant sector in the heart pump-devices market, characterized by their comprehensive range of services, advanced technology offerings, and the ability to manage complex heart conditions. These institutions play a crucial role in patient management and post-operative care, supported by skilled healthcare professionals and infrastructure tailored for intensive treatments. In contrast, Ambulatory Surgical Centers are emerging as key players, focusing on outpatient procedures that enhance patient satisfaction through reduced wait times and lower costs. They provide less invasive options for heart pump device implantation, which not only improves patient turnover but also capitalizes on the shift toward outpatient care models, thus shaping a dynamic landscape in the India heart pump-devices market.

Get more detailed insights about India Heart Pump Devices Market

Key Players and Competitive Insights

The heart pump-devices market in India is characterized by a dynamic competitive landscape, driven by technological advancements and increasing healthcare demands. Major players such as Abbott (US), Medtronic (US), and Boston Scientific (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Abbott (US) has been particularly active in expanding its product portfolio, emphasizing minimally invasive technologies, which aligns with the growing preference for less invasive surgical options among healthcare providers. Medtronic (US), on the other hand, appears to be concentrating on regional expansion, leveraging its established distribution networks to penetrate deeper into tier-2 and tier-3 cities, thereby broadening its customer base. Boston Scientific (US) is also notable for its commitment to digital transformation, integrating advanced data analytics into its product offerings to improve patient outcomes and operational efficiency.
The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing. This approach not only reduces operational costs but also enhances responsiveness to market demands. The competitive structure of the heart pump-devices market is moderately fragmented, with several players vying for market share. However, the collective influence of key players like Abbott, Medtronic, and Boston Scientific is shaping a more consolidated environment, where innovation and strategic collaborations are paramount.
In October 2025, Abbott (US) announced the launch of its latest heart pump device, which incorporates advanced AI algorithms to monitor patient conditions in real-time. This strategic move is significant as it positions Abbott at the cutting edge of technology, potentially improving patient management and outcomes. The integration of AI into heart pump devices may also set a new standard in the industry, compelling competitors to enhance their technological capabilities.
In September 2025, Medtronic (US) entered into a partnership with a leading Indian healthcare provider to establish a network of specialized centers for heart pump therapies. This collaboration is likely to enhance Medtronic's market penetration and provide patients with better access to advanced heart pump technologies. Such strategic alliances are crucial in a market where localized solutions are increasingly favored by healthcare professionals.
In August 2025, Boston Scientific (US) unveiled a new digital platform designed to streamline the management of heart pump devices, allowing healthcare providers to access real-time data and analytics. This initiative underscores the growing trend towards digitalization in the healthcare sector, as providers seek to leverage technology to improve patient care and operational efficiency.
As of November 2025, the competitive trends in the heart pump-devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are playing a pivotal role in shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, it is anticipated that competitive differentiation will evolve, shifting from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine market dynamics, compelling companies to invest in R&D and forge strategic partnerships to maintain a competitive edge.

Key Companies in the India Heart Pump Devices Market include

Industry Developments

The India Heart Pump Devices Market has witnessed significant developments recently, particularly with companies like Medtronic, Abbott Laboratories, and Philips expanding their product portfolios and market presence.

In August 2023, Medtronic launched an advanced left ventricular assist device, aligning with the growing demand for heart failure treatments in India. LivaNova is focusing on increasing its manufacturing capacity in India to meet rising domestic and export demands, while Edwards Lifesciences has been enhancing its distribution network throughout the country.

Moreover, in June 2023, Boston Scientific announced an investment into the development of new heart pump technologies, emphasizing a commitment to innovation in the Indian market. Major mergers and acquisitions have also been observed, such as Abbott Laboratories' acquisition of a local startup specializing in heart recovery devices in July 2023.

The overall growth in market valuation for these companies is anticipated to impact the availability and affordability of heart pump devices in India, catering to the increasing patient population and enhancing healthcare outcomes. Over the last few years, the Indian government has supported health initiatives focusing on cardiovascular diseases, further bolstering the heart pump devices market landscape.

Future Outlook

India Heart Pump Devices Market Future Outlook

The Heart Pump Devices Market in India is projected to grow at a 21.56% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of portable heart pump devices for home care settings.
  • Investment in telehealth solutions for remote patient monitoring.
  • Partnerships with hospitals for integrated heart failure management programs.

By 2035, the heart pump-devices market is expected to achieve substantial growth and innovation.

Market Segmentation

India Heart Pump Devices Market Product Outlook

  • Ventricular assist devices
  • Left ventricular assist devices
  • Right ventricular assist devices
  • Bi-ventricular assist devices
  • Percutaneous ventricular assist devices
  • Transcutaneous ventricular assist devices
  • Intra-Aortic balloon pumps
  • Total artificial heart

India Heart Pump Devices Market Therapy Outlook

  • Bridge-to-candidacy (BTC)
  • Bridge-to-transplant (BTC)
  • Destination therapy (DT)
  • Others

India Heart Pump Devices Market End-User Outlook

  • Hospitals & Clinics
  • Ambulatory surgical centers
  • Research institutes
  • Others

India Heart Pump Devices Market Device Type Outlook

  • Implantable heart pump devices
  • Extracorporeal heart pump devices

Report Scope

MARKET SIZE 2024 46.32(USD Million)
MARKET SIZE 2025 56.31(USD Million)
MARKET SIZE 2035 396.68(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 21.56% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), Cleveland Heart (US), CardiacAssist (US), Syncardia (US), Getinge (SE), LivaNova (GB)
Segments Covered Product, Device Type, Therapy, End-User
Key Market Opportunities Advancements in minimally invasive heart pump-devices enhance patient outcomes and expand market potential.
Key Market Dynamics Rising demand for advanced heart pump devices driven by regulatory support and technological innovations in India.
Countries Covered India
Leave a Comment

FAQs

What is the expected market size of the India Heart Pump Devices Market in 2024?

The India Heart Pump Devices Market is expected to be valued at 37.0 million USD in 2024.

What will be the projected market value of the India Heart Pump Devices Market by 2035?

By 2035, the overall market for India Heart Pump Devices is expected to reach 300.0 million USD.

What is the projected CAGR for the India Heart Pump Devices Market from 2025 to 2035?

The anticipated CAGR for the India Heart Pump Devices Market from 2025 to 2035 is 20.956%.

Which product segment is expected to dominate the India Heart Pump Devices Market by 2035?

By 2035, the Left Ventricular Assist Devices segment is projected to reach a market value of 86.0 million USD.

What was the market value of Ventricular Assist Devices in 2024?

In 2024, the Ventricular Assist Devices segment was valued at 8.5 million USD.

What key players are competing in the India Heart Pump Devices Market?

Major players in the market include Medtronic, LivaNova, Edwards Lifesciences, and Abbott Laboratories.

How much is the Right Ventricular Assist Devices segment expected to be valued at by 2035?

The Right Ventricular Assist Devices segment is expected to reach a value of 46.0 million USD by 2035.

What will the market size for Percutaneous Ventricular Assist Devices be in 2024?

The market for Percutaneous Ventricular Assist Devices is projected to be valued at 6.0 million USD in 2024.

What are the expected growth opportunities in the Heart Pump Devices Market in India?

The market is expected to grow significantly due to advancements in technology and increasing prevalence of heart diseases.

What challenges might the India Heart Pump Devices Market face in the coming years?

Challenges may include regulatory hurdles and high costs associated with heart pump devices.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions